propranolol has been researched along with methylphenidate in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (44.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ho, BT; Silverman, PB | 1 |
| Davydova, ON; Krendal', FP; Kudrin, AN | 1 |
| Cadieux, R; Kales, A; Soldatos, CR; Tan, TL | 1 |
| Bixler, EO; Cadieux, R; Kales, A; Scharf, MB; Soldatos, CR; Tan, TL | 1 |
| Aguggia, M; Cantello, R; Delsedime, M; Gilli, M; Mutani, R; Rainero, I; Riccio, A | 1 |
| Cope, DN; Haas, JF | 1 |
| Chang, KJ; Ferris, RM; Russell, A; Tang, FL | 1 |
| Brichard, G | 1 |
| Caldwell, RW; Goldberg, LI | 1 |
| Brody, TM; McNeill, JH | 1 |
| Delashaw, JB; Dement, WC; Foutz, AS; Guilleminault, C | 1 |
| Chavez, H; Losek, JD; Ozolins, D | 1 |
| Fleminger, S; Greenwood, RJ; Oliver, DL | 2 |
| Davis, A; Ernst, M; Grillon, C; Lago, T | 1 |
4 review(s) available for propranolol and methylphenidate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Discriminative response control by psychomotor stimulants.
Topics: Animals; Atropine; Central Nervous System Stimulants; Cinanserin; Cocaine; Dextroamphetamine; Discrimination, Psychological; DOM 2,5-Dimethoxy-4-Methylamphetamine; Methylphenidate; p-Hydroxyamphetamine; Phenoxybenzamine; Propranolol; Rats; Time Factors | 1976 |
Pharmacological management for agitation and aggression in people with acquired brain injury.
Topics: Adrenergic beta-Antagonists; Aggression; Amantadine; Anxiety; Brain Injuries; Humans; Methylphenidate; Neuroprotective Agents; Pindolol; Propranolol; Randomized Controlled Trials as Topic | 2003 |
Pharmacological management for agitation and aggression in people with acquired brain injury.
Topics: Adrenergic beta-Antagonists; Aggression; Amantadine; Anxiety; Brain Injuries; Humans; Methylphenidate; Neuroprotective Agents; Pindolol; Propranolol; Psychomotor Agitation; Randomized Controlled Trials as Topic | 2006 |
3 trial(s) available for propranolol and methylphenidate
| Article | Year |
|---|---|
Analgesic action of methylphenidate on parkinsonian sensory symptoms. Mechanisms and pathophysiological implications.
Topics: Aged; Analgesics; Biogenic Amines; Biomechanical Phenomena; Humans; Male; Methylphenidate; Methysergide; Middle Aged; Palliative Care; Parkinson Disease; Premedication; Propranolol; Sensation | 1988 |
[Practolol in anesthesia (ICI 50.172, Eraldin)].
Topics: Acetanilides; Adolescent; Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Amino Alcohols; Anesthesia, Inhalation; Arrhythmias, Cardiac; Blood Pressure; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Electrocardiography; Humans; Hypertension; Infant; Methylphenidate; Middle Aged; Plethysmography; Propranolol; Propylamines; Seizures; Time Factors; Valsalva Maneuver | 1972 |
The effects of methylphenidate and propranolol on the interplay between induced-anxiety and working memory.
Topics: Adrenergic beta-Antagonists; Adult; Anxiety; Attention; Central Nervous System Stimulants; Double-Blind Method; Female; Healthy Volunteers; Humans; Male; Memory, Short-Term; Methylphenidate; Propranolol; Young Adult | 2016 |
18 other study(ies) available for propranolol and methylphenidate
| Article | Year |
|---|---|
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
[Pharmacologic incompatibility of neuroleptics and tranquilizers with other medicines].
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cardiac Glycosides; Cats; Drug Interactions; Haloperidol; Humans; Hypertension; Lithium; Methyldopa; Methylphenidate; Monoamine Oxidase Inhibitors; Parasympatholytics; Phenothiazines; Propranolol; Tranquilizing Agents | 1977 |
Successful treatment of narcolepsy with propranolol: a case report.
Topics: Female; Humans; Methylphenidate; Middle Aged; Narcolepsy; Propranolol | 1979 |
Propranolol in the treatment of narcolepsy.
Topics: Adult; Aged; Cataplexy; Female; Humans; Male; Methylphenidate; Middle Aged; Narcolepsy; Placebos; Propranolol | 1979 |
Neuropharmacologic management of behavior sequelae in head injury: a case report.
Topics: Adult; Aggression; Anti-Anxiety Agents; Antipsychotic Agents; Behavior; Craniocerebral Trauma; Humans; Lithium; Lithium Carbonate; Male; Methylphenidate; Propranolol; Psychomotor Agitation; Psychotropic Drugs | 1985 |
Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brain.
Topics: Animals; Antipsychotic Agents; Apomorphine; Binding, Competitive; Brain; Carbazoles; Clozapine; Guinea Pigs; Kinetics; Male; Methylphenidate; Mice; Phenazocine; Phencyclidine; Phenoxybenzamine; Propranolol; Receptors, Opioid; Receptors, sigma; Sulpiride | 1986 |
An evaluation of the vasodilation produced by mephentermine and certain other sympathomimetic amines.
Topics: Animals; Arteries; Atropine; Blood Flow Velocity; Chemical Phenomena; Chemistry; Dextroamphetamine; Dogs; Ephedrine; Femoral Artery; Histamine H1 Antagonists; Isoproterenol; Mephentermine; Mesenteric Arteries; Metaraminol; Methamphetamine; Methylphenidate; Muscle Contraction; Nitroglycerin; Phenoxybenzamine; Portal Vein; Propranolol; Regional Blood Flow; Renal Artery; Reserpine; Sympathomimetics; Vascular Resistance; Vasodilator Agents | 1970 |
The effect of various drug pretreatments on amine-induced phosphorylase activation and amine uptake.
Topics: Amitriptyline; Animals; Carbon Isotopes; Depression, Chemical; Desipramine; Diphenhydramine; Drug Synergism; Female; Glucosyltransferases; Heart; Imipramine; Isoproterenol; Methylphenidate; Myocardium; Norepinephrine; Promethazine; Propranolol; Rats; Stimulation, Chemical; Tranylcypromine; Triprolidine; Tritium; Tyramine | 1968 |
Monoaminergic mechanisms and experimental cataplexy.
Topics: Animals; Antidepressive Agents, Tricyclic; Biogenic Amines; Cataplexy; Dogs; Female; Fluoxetine; Haloperidol; Humans; Male; Methylphenidate; Monoamine Oxidase Inhibitors; Physostigmine; Pimozide; Propranolol; Sleep, REM; Sodium Oxybate | 1981 |
Hypoglycemia and propranolol in pediatric behavioral disorders.
Topics: Adrenergic beta-Antagonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Drug Therapy, Combination; Female; Glasgow Coma Scale; Humans; Hypoglycemia; Male; Methylphenidate; Propranolol | 1999 |